Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Aim</h3><p>A predictive model using left atrial function indexes obtained by real‐time three‐dimensional echocardiography (RT‐3DE) and the blood B‐type natriuretic peptide (BNP) level was constructed, and its value in predicting recurrence in patients with early persistent atrial fibrillation (AF) after radiofrequency ablation was explored.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>A total of 228 patients with early persistent AF who were scheduled to receive the first circular pulmonary vein ablation (CPVA) were enrolled. Clinical data of patients were collected: (1) The blood BNP level was measured before radiofrequency ablation; (2) RT‐3DE was used to obtain the left atrial (LA) time‐volume curve; (3) The clinical characteristics, BNP level and LA function parameters were compared, and logistic regression was used to construct a prediction model with combined parameters; (4) The receiver operating characteristic (ROC) curve was used to examine the diagnostic efficacy of the model.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>(1) 215 patients with early persistent AF completed CPVA and the follow‐up. After 3–6 months of follow‐up, the patients were divided into sinus rhythm group (160 cases) and recurrence group (55 cases); (2) The recurrence group showed higher minimum LA volume index, diastolic ejection index, and preoperative BNP (all <i>p</i> ≤ .001), while the sinus rhythm group exhibited higher expansion index (PI) and left atrial appendage peak emptying velocity (<i>p</i> ≤ .001); (3) In univariate analysis, BNP level had the best diagnostic performance in predicting the recurrence of AF(AUC = 0.703). We constructed a model based on LA function and BNP level to predict the recurrence of persistent AF after CPVA. This combined model was better than BNP alone in predicting the recurrence of persistent AF after CPVA (AUC: 0.814 vs. 0.703, z = 2.224, <i>p</i> = .026). </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusion</h3><p>The combined model of LA function and blood BNP level has good predictive value for the recurrence of early persistent AF after CPVA.</p></section>

Relationship Between Brain Natriuretic Peptide and Recurrence of Atrial Fibrillation after Successful Electrical Cardioversion: A Meta-Analysis

Association Between Baseline Natriuretic Peptides and Atrial Fibrillation Recurrence after Catheter Ablation.

Effects of Percutaneous Balloon Mitral Valvuloplasty on Plasma B-type Natriuretic Peptide in Rheumatic Mitral Stenosis with and Without Atrial Fibrillation.

Clinical Significance and Level of Blood B NP in Patients with Persistent Atrial Fibrillation before and after Catheter Ablation

Relationship between the extent of coronary artery lesions and plasma brain natriuretic peptide

Changes of Plasma Brain Natriuretic Peptide Levels Before and after Catheter Ablation in Patients with Persistent Atrial Fibrillation

Correlation between plasma brain natriuretic peptides and atrial stunningin patients with atrial fibrillation after cardioversion

The Correlation Of Left Ventricular Remodeling And Plasma Brain Natriuretic Peptide Undergoing Different Reperfusion In Patients With First ST-segment Elevation Acute Anterior Myocardial Infarction 1

Association Between Left Atrial Appendage Emptying Velocity, N-Terminal Plasma Brain Natriuretic Peptide Levels, and Recurrence of Atrial Fibrillation after Catheter Ablation

Influence of Atrial Fibrillation Type on Plasma Brain Natriuretic Peptide Level in Male Patients

Relationship between Brain Natriuretic Peptide and Thromboembolic Events in Elderly Patients with Nonvalvular Atrial Fibrillation

Clinical Utility of Baseline Brain Natriuretic Peptide Levels on Health Status Outcomes after Catheter Ablation for Atrial Fibrillation in Individuals without Heart Failure

Brain Natriuretic Peptide and Optimal Management of Heart Failure.

Correlation between heart rate variability and brain natriuretic peptide in patients with persistent atrial fibrillation

Effects of Recombinant Human Brain Natriuretic Peptide on Atrial Fibrillation After Coronary Artery Bypass Grafting

Plasma N-terminal Pro-Brain Natriuretic Peptide Levels Predict New-Onset Atrial Fibrillation in Patients with Acute Myocardial Infarction

The Effect of Renin-Angiotensin System Inhibitors on the Recurrence of Atrial Fibrillation After Catheter Ablation A Systematic Review and Meta-Analysis

Use of B-type Natriuretic Peptide in Evaluation of Early Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome.

Biomarkers as predictors of recurrence of atrial fibrillation post ablation: an updated and expanded systematic review and meta-analysis

A predictive model using left atrial function and B‐type natriuretic peptide level in predicting the recurrence of early persistent atrial fibrillation after radiofrequency ablation

Correlation Between Brain Natriuretic Peptide Levels and the Prognosis of Patients with Left Ventricular Diastolic Dysfunction.